BioSpace News Archive

Curis, Inc. reported its financial results for the first quarter ended March 31, 2022 and provided business updates.

Ardelyx, Inc. provided a business update and reported financial results for the first quarter ended March 31, 2022.

BioMarin Pharmaceutical Inc. announced that the Company hired two pharmaceutical industry leaders in their respective areas of expertise.

Tivity Health, Inc. (Nasdaq: TVTY) (the “Company”), a leading provider of healthy life-changing solutions, including SilverSneakers®, today announced financial results for the first quarter ended March 31, 2022.

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced that it will report its first quarter 2022 financial results on Thursday, May 12, 2022, after the U.S. financial markets close.

Tyra Biosciences, Inc. reported financial results for the quarter ended March 31, 2022 and highlighted recent corporate progress.

Illumina, Inc. announced its financial results for the first quarter of fiscal year 2022, which include consolidated financial results for GRAIL.

Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced financial results for the three months ended March 31, 2022.

Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today reported financial results for the first quarter of 2022.

Twist Bioscience Corporation reported financial results and business highlights for the second quarter of fiscal 2022 ended March 31, 2022.